Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease

Blood Adv. 2023 May 23;7(10):1987-1990. doi: 10.1182/bloodadvances.2022008574.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / drug therapy
  • Antibodies, Monoclonal, Humanized
  • Humans

Substances

  • sutimlimab
  • Antibodies, Monoclonal, Humanized